Pamela Beatty

786 total citations
21 papers, 509 citations indexed

About

Pamela Beatty is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Pamela Beatty has authored 21 papers receiving a total of 509 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 10 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Pamela Beatty's work include Immunotherapy and Immune Responses (10 papers), Glycosylation and Glycoproteins Research (8 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Pamela Beatty is often cited by papers focused on Immunotherapy and Immune Responses (10 papers), Glycosylation and Glycoproteins Research (8 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Pamela Beatty collaborates with scholars based in United States, Italy and China. Pamela Beatty's co-authors include Olivera J. Finn, Sarangarajan Ranganathan, Scott E. Plevy, Antonia R. Sepulveda, Robert E. Schoen, Peiwen Ma, John McKolanis, Sowmya Narayanan, Jean Gariépy and Deepak K. Kadayakkara and has published in prestigious journals such as The Journal of Immunology, Gastroenterology and Cancer Research.

In The Last Decade

Pamela Beatty

20 papers receiving 505 citations

Peers

Pamela Beatty

IMMUN

ONCOL

GENET

SURGE

Ruby Alonso Cuba

Sara Burkhard Switzerland

Khue G. Nguyen United States

Reshmi Parameswaran United States

Iñigo Tirapu Spain

Mina O. Seedhom United States

Cinzia Remondo Italy

Jaina M. Patel United States

Mark J. Dobrzanski United States

Jennifer B. Jacob United States

Ruby Alonso Cuba

Pamela Beatty

422 ×1.3

IMMUN

209 ×0.9

ONCOL

152 ×0.8

48 ×0.6

GENET

26 ×0.4

SURGE

Citations per year, relative to Pamela Beatty Pamela Beatty (= 1×) peers Ruby Alonso

Countries citing papers authored by Pamela Beatty

Since Specialization

Citations

This map shows the geographic impact of Pamela Beatty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pamela Beatty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pamela Beatty more than expected).

Fields of papers citing papers by Pamela Beatty

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pamela Beatty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pamela Beatty. The network helps show where Pamela Beatty may publish in the future.

Co-authorship network of co-authors of Pamela Beatty

This figure shows the co-authorship network connecting the top 25 collaborators of Pamela Beatty. A scholar is included among the top collaborators of Pamela Beatty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pamela Beatty. Pamela Beatty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Beatty, Pamela, Irene K. Yan, Raouf E. Nakhleh, et al.. (2023). S1508 Patterns of Abnormal MUC1 Expression in Patients with PSC and Cholangiocarcinoma. The American Journal of Gastroenterology. 118(10S). S1143–S1144.

Mohseni, Amir Hossein, Sedigheh Taghinezhad‐S, Pamela Beatty, & Olivera J. Finn. (2023). Abstract 644: Gut microbiota-derived metabolites as regulators of immunity in pre-cancer. Cancer Research. 83(7_Supplement). 644–644. 3 indexed citations

Beatty, Pamela, et al.. (2020). Myeloid derived suppressor cells in cancer, premalignancy and inflammation: A roadmap to cancer immunoprevention. Molecular Carcinogenesis. 59(7). 852–861. 10 indexed citations

Ma, Peiwen, et al.. (2019). Circulating Myeloid Derived Suppressor Cells (MDSC) That Accumulate in Premalignancy Share Phenotypic and Functional Characteristics With MDSC in Cancer. Frontiers in Immunology. 10. 83 indexed citations

Schoen, Robert E., Lisa A. Boardman, Marcia Cruz‐Correa, et al.. (2018). Mo1987 - Randomized, Double-Blind, Placebo-Controlled Immunoprevention Trial with MUC1 Vaccine in Patients with Newly Diagnosed Advanced Adenomas. Gastroenterology. 154(6). S–873. 1 indexed citations

Ma, Peiwen, et al.. (2018). Myeloid derived suppressor cells (MDSC) and anti-MUC1 immunosurveillance in pre-malignancy and cancer. The Journal of Immunology. 200(Supplement_1). 122.17–122.17. 1 indexed citations

Schoen, Robert E., Lisa A. Boardman, Marcia Cruz‐Correa, et al.. (2018). Abstract LB-305: Randomized, double-blind, placebo-controlled immunoprevention trial with MUC1 vaccine in patients with newly diagnosed advanced adenomas. Cancer Research. 78(13_Supplement). LB–305. 1 indexed citations

Cascio, Sandra, Joshua Sciurba, Xue Jia, et al.. (2017). Abnormally glycosylated MUC1 establishes a positive feedback circuit of inflammatory cytokines, mediated by NF-κB p65 and EzH2, in colitis-associated cancer. Oncotarget. 8(62). 105284–105298. 17 indexed citations

Beatty, Pamela, Jana G. Hashash, Takashi Kimura, et al.. (2016). Immunobiology and immunosurveillance in patients with intraductal papillary mucinous neoplasms (IPMNs), premalignant precursors of pancreatic adenocarcinomas. Cancer Immunology Immunotherapy. 65(7). 771–778. 31 indexed citations

10.

Finn, Olivera J. & Pamela Beatty. (2016). Cancer immunoprevention. Current Opinion in Immunology. 39. 52–58. 43 indexed citations

11.

Hashash, Jana G., Pamela Beatty, Miguel Regueiro, et al.. (2016). Abnormal MUC1 Expression in Post-operative Crohnʼs Disease Recurrence. The American Journal of Gastroenterology. 111. S306–S307. 1 indexed citations

12.

Beatty, Pamela, et al.. (2013). Influenza Virus Infection Elicits Protective Antibodies and T Cells Specific for Host Cell Antigens Also Expressed as Tumor-Associated Antigens: A New View of Cancer Immunosurveillance. Cancer Immunology Research. 2(3). 263–273. 31 indexed citations

13.

Beatty, Pamela & Olivera J. Finn. (2013). Preventing cancer by targeting abnormally expressed self‐antigens: MUC1 vaccines for prevention of epithelial adenocarcinomas. Annals of the New York Academy of Sciences. 1284(1). 52–56. 19 indexed citations

14.

Beatty, Pamela, Sarangarajan Ranganathan, & Olivera J. Finn. (2012). Prevention of colitis-associated colon cancer using a vaccine to target abnormal expression of the MUC1 tumor antigen. OncoImmunology. 1(3). 263–270. 21 indexed citations

15.

Finn, Olivera J., et al.. (2011). Importance of MUC1 and spontaneous mouse tumor models for understanding the immunobiology of human adenocarcinomas. Immunologic Research. 50(2-3). 261–268. 37 indexed citations

16.

Beatty, Pamela, Sandra Cascio, & Eric R. Lutz. (2011). Tumor Immunology: Basic and Clinical Advances. Cancer Research. 71(13). 4338–4343. 8 indexed citations

17.

Beatty, Pamela, Sowmya Narayanan, Jean Gariépy, Sarangarajan Ranganathan, & Olivera J. Finn. (2010). Vaccine against MUC1 Antigen Expressed in Inflammatory Bowel Disease and Cancer Lessens Colonic Inflammation and Prevents Progression to Colitis-Associated Colon Cancer. Cancer Prevention Research. 3(4). 438–446. 62 indexed citations

18.

Kadayakkara, Deepak K., Pamela Beatty, Michael S. Turner, et al.. (2010). Inflammation Driven by Overexpression of the Hypoglycosylated Abnormal Mucin 1 (MUC1) Links Inflammatory Bowel Disease and Pancreatitis. Pancreas. 39(4). 510–515. 62 indexed citations

19.

Beatty, Pamela, Scott E. Plevy, Antonia R. Sepulveda, & Olivera J. Finn. (2007). Cutting Edge: Transgenic Expression of Human MUC1 in IL-10−/− Mice Accelerates Inflammatory Bowel Disease and Progression to Colon Cancer. The Journal of Immunology. 179(2). 735–739. 61 indexed citations

20.

Beatty, Pamela. (2006). MUC1 in the relationship between inflammation and cancer in IBD. D-Scholarship@Pitt (University of Pittsburgh). 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact